# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Dec 15, 2023

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2023-12-15
- Accepted by EDGAR: Dec 15, 2023, 16:10 ET
- Period: 2023-12-15
- Accession: 0001104659-23-126400
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000110465923126400/tm2332971d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000110465923126400/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000110465923126400/tm2332971d1_8k.htm

Filed Dec 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-126400. Last ingested by Listed: Nov 15, 2026, 04:18 ET. No prices; not investment advice.
